Literature DB >> 25632935

MicroRNAs in the biology and diagnosis of cholangiocarcinoma.

Klaus Piontek1, Florin M Selaru1.   

Abstract

Ever since their discovery, microRNAs (miRNAs) have been the subject of intense investigation of their roles in cells and tissues, both normal and disease state. Although some of the precise mechanisms of biogenesis and actions of miRNAs remain debatable, the fact that miRNAs are dysregulated in diseases such as cancer is undisputed. For many miRNA species, computational databases predict often numerous targets; however, experimental verification in vitro and in vivo is still lacking. For some miRNAs, species-specific targets have been validated; nevertheless, the precise mechanisms those targets act in and whether they are the only truly important ones remain to be discovered. The authors take a closer look at the current status of the role of miRNAs in the diagnosis and biology of cholangiocarcinomas where the perhaps biggest impact in the short term comes from the use of biomarkers in the early diagnosis. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25632935     DOI: 10.1055/s-0034-1397349

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  9 in total

Review 1.  The role of miRNAs in cholangiocarcinoma.

Authors:  Jessica A Howell; Shahid A Khan
Journal:  Hepat Oncol       Date:  2016-03-29

2.  Upregulated lncRNA-UCA1 contributes to metastasis of bile duct carcinoma through regulation of miR-122/CLIC1 and activation of the ERK/MAPK signaling pathway.

Authors:  Lei Kong; Qinghua Wu; Liangchao Zhao; Jinhua Ye; Nengping Li; Huali Yang
Journal:  Cell Cycle       Date:  2019-05-20       Impact factor: 4.534

Review 3.  Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.

Authors:  Yu-Cheng Zhang; Zhuo Xu; Tian-Fu Zhang; Ya-Li Wang
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

4.  MicroRNA-26b-5p regulates cell proliferation, invasion and metastasis in human intrahepatic cholangiocarcinoma by targeting S100A7.

Authors:  Fei Fan; Jiongjiong Lu; Wenlong Yu; Yongjie Zhang; Suqian Xu; Leilei Pang; Bin Zhu
Journal:  Oncol Lett       Date:  2017-11-02       Impact factor: 2.967

Review 5.  The Emerging Role of miRNAs and Their Clinical Implication in Biliary Tract Cancer.

Authors:  Nina Nayara Ferreira Martins; Kelly Cristina da Silva Oliveira; Amanda Braga Bona; Marília de Arruda Cardoso Smith; Geraldo Ishak; Paulo Pimentel Assumpção; Rommel Rodríguez Burbano; Danielle Queiroz Calcagno
Journal:  Gastroenterol Res Pract       Date:  2016-12-27       Impact factor: 2.260

6.  Serum microRNAs as Biomarkers for the Noninvasive Early Diagnosis of Biliary Tract Cancer.

Authors:  Yueting Han; Haiyang Zhang; Zhengyang Zhou; Rui Liu; Dongying Liu; Ming Bai; Qian Fan; Jialu Li; Kegan Zhu; Hongli Li; Tao Ning; Guoguang Ying; Yi Ba
Journal:  Int J Gen Med       Date:  2021-04-01

Review 7.  Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?

Authors:  Simone Brivio; Massimiliano Cadamuro; Luca Fabris; Mario Strazzabosco
Journal:  J Clin Med       Date:  2015-12-19       Impact factor: 4.241

8.  Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer Patients.

Authors:  Romana Urbas; Christian Mayr; Eckhard Klieser; Julia Fuereder; Doris Bach; Stefan Stättner; Florian Primavesi; Tarkan Jaeger; Stefanie Stanzer; Anna Lena Ress; Magdalena Löffelberger; Andrej Wagner; Frieder Berr; Markus Ritter; Martin Pichler; Daniel Neureiter; Tobias Kiesslich
Journal:  Int J Mol Sci       Date:  2016-12-07       Impact factor: 5.923

Review 9.  The Crosstalk of miRNA and Oxidative Stress in the Liver: From Physiology to Pathology and Clinical Implications.

Authors:  Eckhard Klieser; Christian Mayr; Tobias Kiesslich; Till Wissniowski; Pietro Di Fazio; Daniel Neureiter; Matthias Ocker
Journal:  Int J Mol Sci       Date:  2019-10-23       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.